EuroPCR 2022

18 May 2022

Stents, scaffolds and DCB

Cre8 EVO: the "sweetest advancement" that a diabetic patient is waiting for

Sponsored by Alvimedica

Anchorperson: M. Valgimigli

Moderator: R. Byrne

SHOW MORE

Summary

Thanks to a mix between cases and live lectures and discussions, this EuroPCR 2022 session will enable you to review the challenges of a PCI and the one-year results of the SUGAR RCT in diabetes mellitus patients, and to understand how to maximise PCI outcomes, especially by using Cre8 EVO unique technology in those patients.

Learning Objectives

To review the challenges of a PCI in a diabetes mellitus patient
To know how to maximise the outcome of PCI in a diabetic patient
To understand how Cre8 EVO unique technologies provide superior outcomes in diabetes mellitus patients
To review the one-year results of the SUGAR RCT in diabetes mellitus patients

Marco Valgimigli

Speaker

Session objectives

Download presentation

Rosli Mohd Ali

Speaker

Case presentation

Download presentation

Speaker

Paving the way for an effective PCI in diabetes mellitus patients: Cre8 EVO unique technologies

Download presentation

Rafael Romaguera

Speaker

The SUGAR trial: one-year results of the largest randomised controlled trial with latest DES in diabetes mellitus patients

Download presentation

Marco Valgimigli

Speaker

Session evaluation and key learnings

Download presentation